Urine test could reduce unnecessary prostate biopsies
Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is.
Based on technology previously reported, the so-called ‘ExoGrail’ test could revolutionise how patients with suspected prostate cancer are risk-assessed. The research team say their new test could reduce the number of prostate biopsies carried out by 35%.
Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man’s lifetime. However, doctors struggle to predict which tumours will become aggressive, making it hard to decide on treatment for many men.
'Over-diagnosis and overtreatment'
Lead researcher Dr Dan Brewer, from UEA’s Norwich Medical School, said: 'While prostate cancer is responsible for a large proportion of all male cancer deaths, it is more commonly a disease men die with rather than from.
'Therefore, there is a desperate need for improvements in diagnosing and predicting outcomes for prostate cancer patients to minimise over-diagnosis and overtreatment whilst appropriately treating men with aggressive disease, especially if this can be done without taking an invasive biopsy. Invasive biopsies come at considerable economic, psychological and societal cost to patients and healthcare systems alike.'
The ExoGrail urine test combines two biomarker sources: measurements of a protein-marker called EN2 and the levels of gene expression of 10 genes related to prostate cancer risk. It builds on previously developed tests called PUR and ExoMeth.
Home urine test
Researchers are also trialling a new home urine-testing kit across the UK, Europe and Canada.
The Men’s Health Forum need your support It’s tough for men to ask for help but if you don’t ask when you need it, things generally only get worse. So we’re asking. In the UK, one man in five dies before the age of 65. If we had health policies and services that better reflected the needs of the whole population, it might not be like that. But it is. Policies and services and indeed men have been like this for a long time and they don’t change overnight just because we want them to. It’s true that the UK’s men don’t have it bad compared to some other groups. We’re not asking you to ‘feel sorry’ for men or put them first. We’re talking here about something more complicated, something that falls outside the traditional charity fund-raising model of ‘doing something for those less fortunate than ourselves’. That model raises money but it seldom changes much. We’re talking about changing the way we look at the world. There is nothing inevitable about premature male death. Services accessible to all, a population better informed. These would benefit everyone - rich and poor, young and old, male and female - and that’s what we’re campaigning for. We’re not asking you to look at images of pity, we’re just asking you to look around at the society you live in, at the men you know and at the families with sons, fathers and grandads missing. Here’s our fund-raising page - please chip in if you can. |